A new study published in the Journal of Drugs in Dermatology finds that many people misunderstand how common skin, hair, and nail side effects are during cancer treatment — and those fears may lead some to avoid or delay care.
Conducted by researchers at the George Washington University and Georgetown University, the study surveyed attendees at two health fairs in medically underserved areas of Southeast Washington, D.C. Most of the participants were women and Black or African American adults.
Researchers found that many people believe hair loss, rashes, and nail changes happen more often than they actually do during anti-cancer therapies - known as dermatologic side effects.
Key Findings:
- One-third of participants said permanent hair loss might make them refuse treatment.
- Half of cancer survivors surveyed never saw a dermatologist while receiving care.
- Over one-third of all respondents said side effects like hair or nail changes could lead them to turn down treatment.
“These findings show how powerful fear and misunderstanding can be,” said senior author Adam Friedman, Chair of Dermatology at GW. “We need better education and support to help patients make informed choices.”
The researchers recommend stronger partnerships between dermatologists, oncologists, and primary care doctors to ensure patients understand side effects and available treatments.
The study, “Perceptions and Knowledge of Dermatologic Side Effects of Anti-Cancer Therapies: A Pilot Survey” was published in the Journal of Drugs in Dermatology.
-GW-